🔎 Trials Near Me

Akèy › Hypertension artérielle › South Carolina

Etid klinik pou Hypertension artérielle nan South Carolina

14 etid pou Hypertension artérielle ap chèche patisipan nan sit nan South Carolina.

Vil nan South Carolina

Tèks ofisyèl etid la (Anglè)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

  • Retension Clinical Site, Charleston
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07142356

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  • Medical University of South Carolina, Charleston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06059638

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Monroe Biomedical Research - Charleston, North Charleston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Piedmont Research Partners, LLC, Fort Mill
  • Velocity Clinical Research-Gaffney-69046, Gaffney
  • Tribe Clinical Research LLC - Greenville, Greenville
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

  • OnSite Clinical Solutions, LLC, Fort Mill
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07511361

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Care Access - Mauldin, Mauldin
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Charleston
  • Research Site, Columbia
  • Research Site, Orangeburg
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06742723

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • MUSC, Mt. Pleasant
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT06559891

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Columbia
  • Clinical Trial Site, Greenville
  • Clinical Trial Site, Greer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

Improving the Collaborative Health of Adult Dyads

  • University of South Carolina, Columbia
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05370014

Global Paradise System US Post Approval Study

  • Medical University of South Carolina, Charleston
  • Prisma Health Richland Hospital, Columbia
  • Spartanburg Regional Medical Center, Spartanburg
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06297291

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

  • Walker Family Care, Little River
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 30, 2026 · NCT07610278

Community Health Worker Coaching to Reduce Cardiovascular Risk Among Women After a Hypertensive Disorder of Pregnancy

  • University of South Carolina, Columbia
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou May 4, 2026 · NCT07457970

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

  • Vanda Investigative Site, Charleston
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Feb 27, 2026 · NCT07090161

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.